Angela M. Cacace - 23 Feb 2026 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Role
Chief Scientific Officer
Signature
/s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace
Issuer symbol
ARVN
Transactions as of
23 Feb 2026
Net transactions value
-$43,885
Form type
4
Filing time
25 Feb 2026, 17:09:10 UTC
Previous filing
18 Feb 2026
Next filing
02 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cacace Angela M Chief Scientific Officer C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN /s/ Jared Freedberg, as attorney-in-fact for Angela M. Cacace 25 Feb 2026 0002026306

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARVN Common Stock Sale $12,622 -1,038 -0.69% $12.16 150,194 23 Feb 2026 Direct F1
transaction ARVN Common Stock Sale $31,263 -2,571 -1.7% $12.16 147,623 23 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-quarter of the reporting person's restricted stock units (RSUs) granted on February 22, 2023. The sale does not represent a discretionary trade.
F2 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on February 23, 2024. The sale does not represent a discretionary trade.